| Announce Date | 11/20/2025 |
| EPS Normalized Actual | $0.01 (Beat by $0.01007) |
| EPS GAAP Actual | $0.01 (Beat by $0.01007) |
| Revenue Actual | $1.62001B |
| Revenue Surprise | Beat by $1620.01M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $-0.58251 |
| EPS GAAP Estimate | $-0.58251 |
| Revenue Estimate | $0.234614346B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2027 | 3.35342 | 2.92 | 2.55252 | 4.34748 | 3 |
| Dec 2026 | 14.83815 | 0.66 | 6.92777 | 36.11726 | 4 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0 | -1.30697 | 1.62001B | 2.93% | 1354.03M |
| FQ2 2025 (Jun 2025) | -0.15 | 1.53259 | 1.41754B | 6.76% | 1208.68M |
| FQ1 2025 (Mar 2025) | 0.65 | 1.23095 | 1.29826B | -7.21% | 1086.67M |
| FQ4 2024 (Dec 2024) | 0.7 | -0.35877 | 1.3398B | -10.5% | 1108.15M |
| FQ3 2024 (Sep 2024) | 0 | -1.54141 | 1.57254B | 2.15% | -1142.39M |
| FQ2 2024 (Jun 2024) | -0.84 | -0.84 | 1.32172B | 8.71% | 1321.72M |
| FQ1 2018 (Mar 2018) | -0.58 | -0.58 | 0.163578B | 100% | 163.58M |
| FQ2 2018 (Jun 2018) | -0.58 | -0.58 | 0.163578B | 100% | 163.58M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
-0.58251
Consensus Revenue Estimates
0.234614346B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 1.26339 | -- | 1.24432 | 1.28246 | 1 |
| FQ3 2027 (Sep 2027) | 2.08064 | -- | 2.08064 | 2.08064 | 1 |
| FQ2 2027 (Jun 2027) | -0.19004 | -- | -0.19004 | -0.19004 | 1 |
| FQ1 2027 (Mar 2027) | 1.00282 | -- | 0.98768 | 1.01796 | 1 |
| FQ4 2026 (Dec 2026) | 1.89096 | -- | 1.81867 | 1.96325 | 0 |
| FQ3 2026 (Sep 2026) | 1.55502 | -- | 1.49557 | 1.61447 | 0 |
| FQ2 2026 (Jun 2026) | -1.74928 | 91.43 | -1.81616 | -1.6824 | 0 |
| FQ1 2026 (Mar 2026) | -0.58251 | 211.59 | -0.60478 | -0.56024 | 0 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 1.92B | -- | 1.9B | 1.95B | 1 |
| FQ3 2027 (Sep 2027) | 2.28B | -- | 2.28B | 2.28B | 1 |
| FQ2 2027 (Jun 2027) | 1.87B | -- | 1.87B | 1.87B | 1 |
| FQ1 2027 (Mar 2027) | 1.67B | -- | 1.65B | 1.69B | 1 |
| FQ4 2026 (Dec 2026) | 0.28B | -- | 0.27B | 0.29B | 1 |
| FQ3 2026 (Sep 2026) | 0.29B | -455.1 | 0.28B | 0.3B | 1 |
| FQ2 2026 (Jun 2026) | 0.23B | -518.92 | 0.22B | 0.24B | 1 |
| FQ1 2026 (Mar 2026) | 0.23B | -453.36 | 0.23B | 0.24B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
2
EPS # of Misses
6
EPS # of in-lines
0
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 1.30697 | 0 | -1.30697 | -INF% |
| FQ2 2025 (Jun 2025) | -1.68259 | -0.15 | 1.53259 | -1021.73% |
| FQ1 2025 (Mar 2025) | -0.58095 | 0.65 | 1.23095 | 189.38% |
| FQ4 2024 (Dec 2024) | 1.05877 | 0.7 | -0.35877 | -51.25% |
| FQ3 2024 (Sep 2024) | 1.54141 | 0 | -1.54141 | -INF% |
| FQ2 2024 (Jun 2024) | -0.84 | -0.84 | 100% | |
| FQ1 2018 (Mar 2018) | -0.58 | -0.58 | 100% | |
| FQ2 2018 (Jun 2018) | -0.58 | -0.58 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0.27B | $1.62B | $1354.03M | 83.58% |
| FQ2 2025 (Jun 2025) | $0.21B | $1.42B | $1208.68M | 85.27% |
| FQ1 2025 (Mar 2025) | $0.21B | $1.3B | $1086.67M | 83.7% |
| FQ4 2024 (Dec 2024) | $0.23B | $1.34B | $1108.15M | 82.71% |
| FQ3 2024 (Sep 2024) | $2.71B | $1.57B | $-1142.39M | -72.65% |
| FQ2 2024 (Jun 2024) | $0B | $1.32B | $1321.72M | 100% |
| FQ1 2018 (Mar 2018) | $0B | $0.16B | $163.58M | 100% |
| FQ2 2018 (Jun 2018) | $0B | $0.16B | $163.58M | 100% |